<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM">
      <PMID Version="1">29780934</PMID>
      <DateRevised>
        <Year>2022</Year>
        <Month>03</Month>
        <Day>31</Day>
      </DateRevised>
      <Article PubModel="Electronic-eCollection">
        <Journal>
          <ISSN IssnType="Electronic">2451-9936</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>10</Volume>
            <PubDate>
              <Year>2018</Year>
              <Month>Jun</Month>
            </PubDate>
          </JournalIssue>
          <Title>American journal of ophthalmology case reports</Title>
          <ISOAbbreviation>Am J Ophthalmol Case Rep</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Retinal vasculitis associated with CREST syndrome.</ArticleTitle>
        <Pagination>
          <StartPage>185</StartPage>
          <EndPage>188</EndPage>
          <MedlinePgn>185-188</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1016/j.ajoc.2018.02.022</ELocationID>
        <Abstract>
          <AbstractText Label="PURPOSE" NlmCategory="OBJECTIVE">To report two cases of retinal vasculitis associated with CREST syndrome, a novel ocular finding.</AbstractText>
          <AbstractText Label="OBSERVATIONS" NlmCategory="METHODS">We report two cases of patients with CREST syndrome with ocular inflammatory disease. Patient 1 presented with a right unilateral panuveitis with extensive retinal vasculitis and evidence of prior uveitis in the contralateral eye. Patient 2 presented with a left branch retinal artery occlusion and bilateral retinal vasculitis. Both patients underwent treatment with prednisone and mycophenolate motefil.</AbstractText>
          <AbstractText Label="CONCLUSIONS AND IMPORTANCE" NlmCategory="CONCLUSIONS">Retinal vasculitis has not been previously reported in CREST syndrome. Prompt therapy with immunomodulatory therapy can potentially minimize ocular morbidity.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Yang</LastName>
            <ForeName>Sungjae</ForeName>
            <Initials>S</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Ophthalmology, Gangneung Asan Hospital, Ulsan University, Gangneung, South Korea.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Casey Eye Institute, Oregon Health &amp; Science University, Portland, OR 97239, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Kopplin</LastName>
            <ForeName>Laura J</ForeName>
            <Initials>LJ</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Ophthalmology &amp; Visual Sciences, Medical College of Wisconsin Eye Institute, Milwaukee, WI 53226, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Rosenbaum</LastName>
            <ForeName>James T</ForeName>
            <Initials>JT</Initials>
            <AffiliationInfo>
              <Affiliation>Casey Eye Institute, Oregon Health &amp; Science University, Portland, OR 97239, USA.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Division of Arthritis and Rheumatic Diseases, Oregon Health &amp; Science University, 3181 SW Sam Jackson Park Rd, Portland, OR 97239, USA.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Legacy Devers Eye Institute, 1040 NW 22nd Ave, Suite 200, Portland, OR 97210, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <GrantList CompleteYN="Y">
          <Grant>
            <GrantID>R01 EY026572</GrantID>
            <Acronym>EY</Acronym>
            <Agency>NEI NIH HHS</Agency>
            <Country>United States</Country>
          </Grant>
        </GrantList>
        <PublicationTypeList>
          <PublicationType UI="D002363">Case Reports</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2018</Year>
          <Month>03</Month>
          <Day>02</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <MedlineTA>Am J Ophthalmol Case Rep</MedlineTA>
        <NlmUniqueID>101679941</NlmUniqueID>
        <ISSNLinking>2451-9936</ISSNLinking>
      </MedlineJournalInfo>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">CREST syndrome</Keyword>
        <Keyword MajorTopicYN="N">Retinal vasculitis</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2017</Year>
          <Month>12</Month>
          <Day>21</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="revised">
          <Year>2018</Year>
          <Month>2</Month>
          <Day>7</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2018</Year>
          <Month>2</Month>
          <Day>26</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2018</Year>
          <Month>5</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2018</Year>
          <Month>5</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2018</Year>
          <Month>5</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>1</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>epublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">29780934</ArticleId>
        <ArticleId IdType="pmc">PMC5956742</ArticleId>
        <ArticleId IdType="doi">10.1016/j.ajoc.2018.02.022</ArticleId>
        <ArticleId IdType="pii">S2451-9936(17)30385-7</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>Miyawaki S., Asanuma H., Nishiyama S., Yoshinaga Y. Clinical and serological heterogeneity in patients with anticentromere antibodies. J Rheumatol. 2005;32:1488–1494.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">16078324</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gomes Bde A., Santhiago M.R., Magalhaes P., Kara-Junior N., Azevedo M.N., Moraes H.V., Jr. Ocular findings in patients with systemic sclerosis. Clinics (Sao Paulo) 2011;66:379–385.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3071995</ArticleId>
            <ArticleId IdType="pubmed">21552659</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Tailor R., Gupta A., Herrick A., Kwartz J. Ocular manifestations of scleroderma. Surv Ophthalmol. 2009;54:292–304.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">19298906</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>West R.H., Barnett A.J. Ocular involvement in scleroderma. Br J Ophthalmol. 1979;63:845–847.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC1043641</ArticleId>
            <ArticleId IdType="pubmed">526467</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Huerva V., Sanchez M.C. Juxtafoveolar telangiectasis associated with CREST syndrome. Ocul Immunol Inflamm. 2008;16:195–197.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">18716957</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Proctor B., Chang T., Hay D. Parafoveal telangiectasia in association with CREST syndrome. Arch Ophthalmol. 1998;116:814–815.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">9639458</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Akman A., Akova Y.A., Yucel E., Aydin P. Granulomatous anterior uveitis in a patient with CREST syndrome. Ocul Immunol Inflamm. 2000;8:201–203.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">11120581</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Courtade M., Gicquel J.J., Mercie M., Vabres B., Dighiero P. Granulomatous uveitis and CREST syndrome: a case study. J Fr Ophtalmol. 2004;27:918–920.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15547474</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Santos P.S., Oliveira L., Moraes M.F. Granulomatous uveitis, CREST syndrome, and primary biliary cirrhosis. Br J Ophthalmol. 2000;84:548–549.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC1723451</ArticleId>
            <ArticleId IdType="pubmed">10847709</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Silva I., Teixeira A., Oliveira J., Ameida R., Vasconcelos C. Endothelial dysfunction, microvascular damage and ischemic peripheral vasculopathy in systemic sclerosis. Clin Hemorheol Microcirc. 2017;66:117–130.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">28128745</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
